10-Q Filing

TEVOGEN BIO HOLDINGS INC. CIK: 1860871 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001410578-22-002585`
Period End Date	20220630
Filing Date	20220815
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	lgstu-20220630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 44 Income Statement 16 Cash Flow Statement 25 Stockholders Equity 15

Balance Sheet 44 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value, (per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$344.58K	USD	Point-in-time
Preferred stock, par value, (per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$185.65K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$446.61K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$409.11K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$791.19K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$594.75K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses- non current	`PrepaidExpenseNoncurrent`	$145.17K	USD	Point-in-time
Cash and marketable securities held in Trust Account	`AssetsHeldInTrustNoncurrent`	$352.38M	USD	Point-in-time
Cash and marketable securities held in Trust Account	`AssetsHeldInTrustNoncurrent`	$351.92M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$352.98M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$352.85M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$39.38K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$179.23K	USD	Point-in-time
Due to affiliate	`DueToAffiliateCurrent`	$20.00K	USD	Point-in-time
Due to affiliate	`DueToAffiliateCurrent`	$80.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$259.23K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$59.38K	USD	Point-in-time
Derivative warrant liabilities	`SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares`	$420.50K	USD	Point-in-time
Derivative warrant liabilities	`SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares`	$166.75K	USD	Point-in-time
Deferred underwriting fee payable	`DeferredOfferingCostsNoncurrent`	$14.70M	USD	Point-in-time
Deferred underwriting fee payable	`DeferredOfferingCostsNoncurrent`	$14.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.13M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.18M	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-14.05M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-14.23M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquity`	$-14.05M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquity`	$-14.23M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquity`	$-14.25M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquity`	$13.70K	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquity`	-	USD	Point-in-time
TOTAL LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$352.98M	USD	Point-in-time
TOTAL LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$352.85M	USD	Point-in-time

Income Statement 16 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$11.30K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$258.58K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$541.46K	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$11.30K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$258.58K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$541.46K	USD	2 Qtrs
Unrealized gain on investments held in Trust Account	`UnrealizedGainLossOnInvestments`	$327.83K	USD	1 Quarter
Unrealized gain on investments held in Trust Account	`UnrealizedGainLossOnInvestments`	$468.72K	USD	2 Qtrs
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$-253.75K	USD	2 Qtrs
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$-137.75K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$722.47K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$465.58K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-25.99K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$207.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-11.30K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$181.01K	USD	2 Qtrs

Cash Flow Statement 25 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-11.30K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$181.01K	USD	2 Qtrs
Unrealized gain on investments held in Trust Account	`UnrealizedGainLossOnInvestments`	$327.83K	USD	1 Quarter
Unrealized gain on investments held in Trust Account	`UnrealizedGainLossOnInvestments`	$468.72K	USD	2 Qtrs
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$-253.75K	USD	2 Qtrs
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$-137.75K	USD	1 Quarter
General and administrative expenses paid by affiliate	`GeneralAndAdministrativeExpensesPaidByRelatedParties`	$10.48K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-182.67K	USD	2 Qtrs
Due to affiliate	`IncreaseDecreaseInDueToAffiliatesCurrent`	$139.86K	USD	2 Qtrs
Due to affiliate	`IncreaseDecreaseInDueToAffiliatesCurrent`	$814.00	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$60.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-158.94K	USD	2 Qtrs
NET CHANGE IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	-	USD	1 Quarter
NET CHANGE IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-158.94K	USD	2 Qtrs
CASH, BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$344.58K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$185.65K	USD	Point-in-time
CASH, END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
CASH, END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$344.58K	USD	Point-in-time
CASH, END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
CASH, END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$185.65K	USD	Point-in-time
Payment of deferred offering costs by note payable - related party	`PaymentOfDeferredOfferingCostsByNotePayableRelatedParty`	$71.05K	USD	1 Quarter
Deferred offering costs included in accrued offering costs	`DeferredOfferingCostsIncludedInAccruedOfferingCosts`	$50.86K	USD	1 Quarter
Payment of deferred offering costs by the Sponsor in exchange for the issuance of Class B Ordinary Shares	`DeferredOfferingCostsPaidInExchangeForIssuanceOfShares`	$25.00K	USD	1 Quarter

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning	`StockholdersEquity`	$-14.05M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$-14.23M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$-14.25M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$13.70K	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	-	USD	Point-in-time
Issuance of Class B ordinary shares to Sponsor	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$-25.99K	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$207.00K	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$-11.30K	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$181.01K	USD	2 Qtrs
Balance at the end	`StockholdersEquity`	$-14.05M	USD	Point-in-time
Balance at the end	`StockholdersEquity`	$-14.23M	USD	Point-in-time
Balance at the end	`StockholdersEquity`	$-14.25M	USD	Point-in-time
Balance at the end	`StockholdersEquity`	$13.70K	USD	Point-in-time
Balance at the end	`StockholdersEquity`	-	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.